StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories interest Expense ($M) ($M)

Postgres DB financial_values + XBRL

QuarterlyAnnual
Latest, FY2025
493
Period ended Dec 31, 2025
Change on a year earlier
-11.8%
559 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedInterest Expense ($M) ($M)Year on yearSource
FY2025Dec 31, 2025493-11.8%Form 10-K (filed 2026-02-20) ↗
FY2024Dec 31, 2024559-12.2%Form 10-K (filed 2025-02-21) ↗
FY2023Dec 31, 2023637+14.2%Form 10-K (filed 2024-02-16) ↗
FY2022Dec 31, 2022558+4.7%Form 10-K (filed 2023-02-17) ↗
FY2021Dec 31, 2021533-2.4%Form 10-K (filed 2022-02-18) ↗
FY2020Dec 31, 2020546-18.5%Form 10-K (filed 2021-02-19) ↗
FY2019Dec 31, 2019670-18.9%Form 10-K (filed 2020-02-21) ↗
FY2018Dec 31, 2018826-8.6%Form 10-K (filed 2019-02-22) ↗
FY2017Dec 31, 2017904+109.7%Form 10-K (filed 2018-02-16) ↗
FY2016Dec 31, 2016431+164.4%Form 10-K (filed 2017-02-17) ↗
FY2015Dec 31, 2015163+8.7%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 2014150+3.4%Form 10-K (filed 2015-02-27) ↗
FY2013Dec 31, 2013145-54.7%Form 10-K (filed 2015-02-27) ↗
FY2012Dec 31, 2012320-10.9%Form 10-K (filed 2015-02-27) ↗
FY2011Dec 31, 2011359-35.1%Form 10-K (filed 2014-02-21) ↗
FY2010Dec 31, 2010553+6.3%Form 10-K (filed 2011-02-18) ↗

Cite this data

StockData. (2026). Abbott Laboratories Interest Expense ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-int-exp

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.